SCHEMBL29854946

SCHEMBL29854946

O=c1cc(C(F)(F)F)oc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ ALDH1A1 P00352 3/20 0.59
▸ MAPT P10636 2/20 0.59
▸ CYP3A4 P08684 2/20 0.58
▸ CYP1B1 Q16678 2/20 0.58
▸ EPHX2 P34913 1/20 0.58
▸ CYP1A1 P04798 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2E1 P05181 1/20 0.58
▸ CYP2C8 P10632 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ CYP2A6 P11509 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ CYP4B1 P13584 1/20 0.58
▸ CYP2B6 P20813 1/20 0.58
▸ CYP3A5 P20815 1/20 0.58
▸ CYP2A7 P20853 1/20 0.58
▸ CYP3A7 P24462 1/20 0.58
▸ CYP2F1 P24903 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662695 1.00 HPGD (0.59) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL11298351 0.83 TNKS (0.53) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL12867892 0.81 ALOX15 (0.57) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL11291776 0.77 TNKS (0.47) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL40354 0.77 EPHX2 (0.50) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL7372279 0.77 EPHX2 (0.61) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL21623585 0.77 MAPT (0.55) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL28490130 0.76 TNKS (0.50) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL29689973 0.75 KDM4E (1.00) HPGDKDM4EALDH1A1MAPTCYP3A4
SCHEMBL29702211 0.75 NPC1 (0.61) HPGDKDM4EALDH1A1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118125978-A MYC inhibitor and preparation method and application thereof 安徽中医药大学 2024-06-04 — — CN disclosed
WO-2022165432-A1 CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2022-08-04 — — WO disclosed
Send feedback